Smith & Nephew PLC
LSE:SN
Smith & Nephew PLC
LSE:SN
Price:
996.8 GBX
1.14%
Market Closed
Updated:
May 6, 2024
Smith & Nephew PLC
Cash from Operating Activities
|
Smith & Nephew PLC
Cash from Operating Activities Peer Comparison
Comparables:
LIVN
LMDX
EKF
AGL
CREO
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash from Operating Activities
$608m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash from Operating Activities
$74.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Cash from Operating Activities
-$162.1m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash from Operating Activities
£6.3m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
12%
|
|
|
Angle PLC
LSE:AGL
|
Cash from Operating Activities
-£15m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash from Operating Activities
-£25.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Smith & Nephew PLC's Cash from Operating Activities?
Cash from Operating Activities
608m
USD
608m
USD
Based on the financial report for Dec 31, 2023, Smith & Nephew PLC's Cash from Operating Activities amounts to 608m USD.
What is Smith & Nephew PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-8%
-8%
Over the last year, the Cash from Operating Activities growth was 30%. The average annual Cash from Operating Activities growth rates for Smith & Nephew PLC have been -13% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
